- Hong Kong
- /
- Construction
- /
- SEHK:8460
Estimating The Fair Value Of Basetrophy Group Holdings Limited (HKG:8460)
Key Insights
- Using the 2 Stage Free Cash Flow to Equity, Basetrophy Group Holdings fair value estimate is HK$0.18
- Basetrophy Group Holdings' HK$0.18 share price indicates it is trading at similar levels as its fair value estimate
- Peers of Basetrophy Group Holdings are currently trading on average at a 92% premium
Today we will run through one way of estimating the intrinsic value of Basetrophy Group Holdings Limited (HKG:8460) by taking the expected future cash flows and discounting them to their present value. One way to achieve this is by employing the Discounted Cash Flow (DCF) model. Models like these may appear beyond the comprehension of a lay person, but they're fairly easy to follow.
We would caution that there are many ways of valuing a company and, like the DCF, each technique has advantages and disadvantages in certain scenarios. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
View our latest analysis for Basetrophy Group Holdings
Is Basetrophy Group Holdings Fairly Valued?
We use what is known as a 2-stage model, which simply means we have two different periods of growth rates for the company's cash flows. Generally the first stage is higher growth, and the second stage is a lower growth phase. In the first stage we need to estimate the cash flows to the business over the next ten years. Seeing as no analyst estimates of free cash flow are available to us, we have extrapolate the previous free cash flow (FCF) from the company's last reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
Generally we assume that a dollar today is more valuable than a dollar in the future, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) estimate
2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | |
Levered FCF (HK$, Millions) | HK$1.57m | HK$1.67m | HK$1.75m | HK$1.82m | HK$1.88m | HK$1.93m | HK$1.98m | HK$2.03m | HK$2.07m | HK$2.11m |
Growth Rate Estimate Source | Est @ 8.30% | Est @ 6.34% | Est @ 4.96% | Est @ 3.99% | Est @ 3.32% | Est @ 2.84% | Est @ 2.51% | Est @ 2.28% | Est @ 2.12% | Est @ 2.00% |
Present Value (HK$, Millions) Discounted @ 10% | HK$1.4 | HK$1.4 | HK$1.3 | HK$1.2 | HK$1.2 | HK$1.1 | HK$1.0 | HK$0.9 | HK$0.9 | HK$0.8 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = HK$11m
We now need to calculate the Terminal Value, which accounts for all the future cash flows after this ten year period. For a number of reasons a very conservative growth rate is used that cannot exceed that of a country's GDP growth. In this case we have used the 5-year average of the 10-year government bond yield (1.7%) to estimate future growth. In the same way as with the 10-year 'growth' period, we discount future cash flows to today's value, using a cost of equity of 10%.
Terminal Value (TV)= FCF2032 × (1 + g) ÷ (r – g) = HK$2.1m× (1 + 1.7%) ÷ (10%– 1.7%) = HK$25m
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= HK$25m÷ ( 1 + 10%)10= HK$9.6m
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is HK$21m. To get the intrinsic value per share, we divide this by the total number of shares outstanding. Relative to the current share price of HK$0.2, the company appears about fair value at a 0.1% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
The Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. If you don't agree with these result, have a go at the calculation yourself and play with the assumptions. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Basetrophy Group Holdings as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 10%, which is based on a levered beta of 1.217. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Basetrophy Group Holdings
- Debt is not viewed as a risk.
- Shareholders have been diluted in the past year.
- Current share price is below our estimate of fair value.
- Lack of analyst coverage makes it difficult to determine 8460's earnings prospects.
- No apparent threats visible for 8460.
Looking Ahead:
Although the valuation of a company is important, it ideally won't be the sole piece of analysis you scrutinize for a company. It's not possible to obtain a foolproof valuation with a DCF model. Instead the best use for a DCF model is to test certain assumptions and theories to see if they would lead to the company being undervalued or overvalued. For instance, if the terminal value growth rate is adjusted slightly, it can dramatically alter the overall result. For Basetrophy Group Holdings, we've compiled three pertinent factors you should look at:
- Risks: For example, we've discovered 2 warning signs for Basetrophy Group Holdings (1 is potentially serious!) that you should be aware of before investing here.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
- Other Top Analyst Picks: Interested to see what the analysts are thinking? Take a look at our interactive list of analysts' top stock picks to find out what they feel might have an attractive future outlook!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SEHK every day. If you want to find the calculation for other stocks just search here.
Valuation is complex, but we're here to simplify it.
Discover if Basetrophy Group Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:8460
Basetrophy Group Holdings
An investment holding company, operates as a substructure subcontractor in Hong Kong and the People’s Republic of China.
Excellent balance sheet and good value.